Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 35015, Korea.
Environmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
BMB Rep. 2022 Nov;55(11):519-527. doi: 10.5483/BMBRep.2022.55.11.128.
Macrophage activation has long been implicated in a myriad of human pathophysiology, particularly in the context of the dysregulated capacities of an unleashing intracellular or/and extracellular inflammatory response. A growing number of studies have functionally coupled the macrophages' inflammatory capacities with dynamic metabolic reprogramming which occurs during activation, albeit the results have been mostly interpreted through classic metabolism point of view; macrophages take advantage of the rewired metabolism as a source of energy and for biosynthetic precursors. However, a specific subset of metabolic products, namely immune-modulatory metabolites, has recently emerged as significant regulatory signals which control inflammatory responses in macrophages and the relevant extracellular milieu. In this review, we introduce recently highlighted immuno-modulatory metabolites, with the aim of understanding their physiological and pathological relevance in the macrophage inflammatory response. [BMB Reports 2022; 55(11): 519-527].
巨噬细胞激活长期以来一直与人类病理生理学的多种现象相关,尤其是在失控的细胞内或/和细胞外炎症反应的情况下。越来越多的研究已经在功能上把巨噬细胞的炎症能力与激活过程中发生的动态代谢重编程联系起来,尽管这些结果大多是通过经典代谢观点来解释的;巨噬细胞利用重新连接的代谢作为能量来源和生物合成前体。然而,最近出现了一类特定的代谢产物,即免疫调节代谢物,它们作为控制巨噬细胞炎症反应和相关细胞外环境的重要调节信号。在这篇综述中,我们介绍了最近被强调的免疫调节代谢物,目的是了解它们在巨噬细胞炎症反应中的生理和病理相关性。[BMB 报告 2022;55(11):519-527]。